Stefano Masi

Associate Professor

University of Pisa
Country flagItaly

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stefano Masi is an Associate Professor at Università degli Studi di Pisa, Italy. His research focuses on cardiovascular health, including the treatment of periodontitis and its effects on carotid intima-media thickness, as well as the management of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors. He has also contributed to advancements in telemonitoring systems for chronic heart failure and the stratification of cardiovascular risk among various patient populations.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

The emergence of the highly contagious coronavirus disease has led to multiple pandemic waves, resulting in a significant number of hospitalizations and fatalities. Even outside of hospitals, general practitioners have faced serious challenges, stretching their resources and putting themselves at risk of infection. Telemonitoring systems based on Internet of things technology have emerged as valuable tools for remotely monitoring disease progression, facilitating rapid intervention, and reducing the risk of hospitalization and mortality. They allow for personalized monitoring strategies and tailored treatment plans, which are crucial for improving health outcomes. However, determining the appropriate monitoring intensity remains the responsibility of physicians, which poses challenges and impacts their workload, and thus, can hinder timely responses. To address these challenges, this paper proposes an expert system designed to recommend and adjust the monitoring intensity for COVID-19 patients receiving home treatment based on their medical history, vital signs, and reported symptoms. The system underwent initial validation using real-world cases, demonstrating a favorable performance (F1-score of 0.85). Subsequently, once integrated with an Internet of Things telemonitoring system, a clinical trial will assess the system’s reliability in creating telemonitoring plans comparable with those of medics, evaluate its effectiveness in reducing medic–patient interactions or hospitalizations, and gauge patient satisfaction and safety.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (18)

Gianpaolo Reboldi

Professor of Nephrology

Università degli Studi di Napoli Federico II

ITALY
View details

Nicola Riccardo Pugliese

University of Pisa

ITALY
View details

Alessandro Mengozzi

Assistant Professor

University of Pisa

ITALY
View details

Francesca Viazzi

University of Genova

ITALY
View details

ROSARIO CIANCI

Professore Associato di Nefrologia

Sapienza University of Rome

ITALY
View details

Mattia Albiero

Assistant Professor

University of Padova

ITALY
View details

Stefano Taddei

University of Pisa

ITALY
View details

Paolo Palatini

University of Padova

ITALY
View details

Maria Lorenza Muiesan

University of Brescia

ITALY
View details

Gianfranco Parati

Senior Professor of Cardiovascular Medicine, past Director of the School of Specialization in Cardiovascular Diseases

University of Milano-Bicocca

ITALY
View details

Luca Fanucci

Professor

University of Pisa

ITALY
View details

Agostino Virdis

Full Professor of Internal Medicine

University of Pisa

ITALY
View details

Francesco Paneni

University of Zurich

SWITZERLAND
View details

Florian A. Wenzl

University of Zurich

SWITZERLAND
View details

Massimo Cirillo

Professore ordinario di Nefrologia

Università degli Studi di Napoli Federico II

ITALY
View details

Massimo Salvetti

Professor

University of Brescia

ITALY
View details

Andrea Grillo

University of Trieste

ITALY
View details

PIETRO Cirillo

University of Bari Aldo Moro

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.